The cellular fatty acid composition of a gram-negative bacterium associated with cat scratch disease was determined by capillary gas chromatography-mass spectrometry (GC-MS). The fatty acid profile of this organism was distinct from those of other bacteria we have tested and was characterized by an unknown acid which was identified as 11-methyloctadec-12-enoic acid. 
In 1989, an organism was isolated from a tibial biopsy by Geraldine S. Hall, Cleveland Clinic, Cleveland, Ohio, and subsequently received by the Special Bacteriology Reference Laboratory of the Centers for Disease Control through the Ohio State Health Department. This culture, which was designated G1849 by the Special Bacteriology Reference Laboratory, yielded very faint opaque colonies on chocolate agar at 35°C in 48 h and punctate, smooth, gray-white colonies on buffered charcoal-yeast extract agar at 30°C in 72 h. The cells were gram-negative, very delicate, palestaining, thin, slightly curved, short-to medium-length rods and were motile, with a single polar, subpolar, or lateral flagellum. The organism could not be identified by our conventional cultural and biochemical testing scheme (3) . The cellular fatty acid composition of G1849 determined by gas-liquid chromatography (GLC) also differed from those of a large number of diverse bacteria we have tested and contained about 12% unknown acid which had not been observed previously. The mass spectrum of the hydrogenated (reduced) unknown peak at an ECL of 18.407 is shown in Fig. 2 (11) . Further indication of the position of the methyl branch was obtained by complete hydrogenation of the unknown FAME to its corresponding alkane, thereby converting the carboxyl group into a methyl group containing one deuterium atom (1). The resulting mass spectrum of the alkane showed a molecular ion at m/z = 269 and major fragment ions at m/z 126 and m/z 169 (Fig. 3) . The cleavage at the methyl branch produced a deuterium-con- 1-deutero-11-methyloctadecane and confirms the structure of the hydrogenated (reduced) unknown peak as 11-methyloctadecanoic acid methyl ester.
Having established the position of the branched methyl group in the unknown acid, we located the double bond by GC-MS analysis of the dimethyl disulfide derivative prepared from the original FAME sample. The resulting mass spectrum of the FAME-dimethyl disulfide adduct showed a molecular ion at m/z 404 and two major ions at m/z 273 and m/z 131 which were attributable to fragmentation between the two CH3S groups located at the original site of unsaturation. The m/z 131 ion is the aliphatic fragment (w) and the m/z 273 ion is the fragment containing the carboxyl end (A) of the molecule. A fourth major ion was observed at m/z 241 and resulted from the loss of methanol (CH30H) from the A fragment (m/z 273 minus 32 = m/z 241). This fragmentation clearly showed the location of the double bond to be at the w6 (or A12) position. Thus, the combined GLC and GC-MS data firmly established the identity of the unknown peak (ECL, 18.082; Fig. 1 ) as 11-methyloctadec-12-enoic acid. To our knowledge, this acid has not been found previously in bacteria.
The unique fatty acid profile of strain G1492 is easily distinguished from those of other gram-negative bacteria and other bacteria such as mycobacteria and Rothia species, which have also been proposed as the cause of CSD (2, 5) . The mycobacteria contain tuberculostearic (lO-methyloctadecanoic) acid, and Rothia dentocariosa has large amounts of branched-chain acids, which are absent in G1492. Thus, the GLC fatty acid analysis provides a rapid means for comparing the chemical relatedness of suspect CSD isolates; its sensitivity will allow testing of isolates that produce only faint growth on initial culturing (2, 4) . The presence of 11-methyloctadec-12-enoic acid may prove to be a useful chemical marker of these bacteria.
There is no apparent clinical relationship between strains G1492 and G1849. Strain G1492 was from a patient with clinically diagnosed CSD, while strain G1849 was isolated from a subcutaneous abscess which developed in the pretibial region of a 69-year-old man during hospitalization following surgery. However, on the basis of cellular fatty acid compositions, morphological features, biochemical characteristics, and recent DNA studies (D. J. Brenner, personal communication), these two strains appear to be significantly related. The pathogenic potential, if any, of strain G1849 should be studied further. Additional evidence to support G1492 as the etiological agent of CSD requires the isolation, in vitro cultivation, and subsequent bacteriological, chemical, and genetic testing of other isolates from patients with clinically or histologically proved CSD.
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